The NIHR Diabetes Research Network has both a dedicated Co-Director and Industry and Portfolio Lead who specialise in working with the commercial sector providing:

  • Unique access to a broad range of centres in primary and secondary care settings
  • Unparalleled access to newly diagnosed patients with Type 1 diabetes
  • Working relationships with primary care centres and secondary care centres across England

We have experience in working on a large number of different commercial trials with particular expertise in:

  • Cardiovascular outcome trials
  • Monoclonal antibody studies
  • Type 2 diabetes studies in primary care settings

The primary goal of the NIHR Diabetes Research Network is to achieve benefits for people with diabetes, or at risk of developing diabetes, through excellence in clinical research. The aims of the network are:

To facilitate the conduct of randomised prospective trials and other well-designed studies of diabetes, including those for prevention, diagnosis and treatment.